|
As a co-founder of CGS with Richard Hayes, Marcy has been instrumental in building CGS into what it is today: a small but mighty organization that leads the way in confronting eugenic and other pernicious implications of human genetics and assisted reproduction. Under her leadership, CGS has:
-
Launched impactful initiatives and collaborations, including Surrogacy360 (born from a longtime collaboration with Our Bodies Ourselves) and the Assisted Reproductive Technologies Working Group
-
Shaped public and policy discussions on human genome editing – including as the only civil society organization to speak in 2015 at the first International Summit on Human Gene Editing
-
Served as a thought leader and fierce advocate for responsible, ethical, and just uses of human biotechnologies – Marcy and others on the CGS team have published dozens of influential articles, commentaries, op-eds, and blog posts
-
Shaped media and public discourse on human genetic and reproductive technologies – having appeared or been quoted hundreds of times in television, radio, print, and online media
We hope you will join us next month for a virtual event to celebrate Marcy and launch CGS into a new era in the fight for genetic justice (details to come).
This fight is more important than ever: rapidly developing “designer baby” technologies are being pushed by powerful political and commercial forces that are promoting both classic eugenics and a new, market-based techno-eugenics.
We are thrilled that Katie has stepped up to lead CGS at this critical moment. Since joining CGS in 2017, she has developed deep knowledge of the field, strong relationships throughout CGS’ extensive network, and a prominent role in national and international debates on heritable human genome editing. Her work to secure funding for CGS’ Confronting Eugenics initiative has already set CGS on an exciting path to continued impact and growth.
With Katie at the helm, a dedicated group of advisors, and your help, CGS is set to step up the fight for a future where human biotechnologies serve the common good – not billionaires’ disturbing visions of the future.
Your donation at this moment of transition and urgency will help secure the legacy of Marcy’s leadership and boldly launch CGS’ next phase.
Will you join me in showing your continued support for CGS today?
| 
